N4 Group’s final IPO total is €33.1 million, including €7 million of new capital and €26.1 million of shareholder sales. Euronext lists 26 October 2026 as the IPO date at €23.81 a share. The distinction matters: most of the transaction’s gross value is not cash raised by the company.
Final proceeds, not the initial target
The issuer’s 21 October result supersedes the earlier €50 million initial offer described in its prospectus. A planned offer and its final allocation are different stages. An investor comparing fundraising capacity should use the completed allocation announcement, while checking separately whether settlement and trading have occurred.
| Item | Verified disclosure and limits | Official source |
|---|---|---|
| Issuer / venue / stage | N4 Group; Euronext Growth Paris; offer results announced 21 October. Exchange IPO date 26 October 2026. | Exchange record |
| Offer price / nominal value | €23.81 per share / €0.50 nominal value. The offer price is not a live trading quote. | Prospectus, sections 3.1.3 and4.4 |
| Final gross proceeds | €33.1 million: €7 million fresh capital and €26.1 million existing-share sales. | Final result, pages 1–2 |
| Final share allocation | 293,994 new shares and 1,095,836 existing shares; 1,389,830 in total. Global placement 95%; French fixed-price offer 5%. | Final result, page 2 |
| Subscription window | French OPF 9–20 October 2026; closing 17:00 at branches and 20:00 online, Paris time. Global placement 9–21 October, closing 12:00 Paris time. | Prospectus, sections 4.4.1 and5.1.3 |
| Minimum application / order categories | French OPF minimum 1 share, equivalent to €23.81 at the offer price before any charges. A 1 covers 1–250 shares and A 2 the portion above 250. These are order categories, not Indian-style lots. A separate institutional minimum is not established in this review. | Prospectus, section 5.1.3 |
| Net new-share proceeds / intended use | Estimated €6.14 million net: about 70% for N4 Labs industrial capacity and 30% for international expansion. Existing-share proceeds go to selling holders, not N4. | Final result, page 2 |
| Settlement / admission timetable | Issuer scheduled settlement for 23 October and trading for 26 October. Euronext lists 26 October as the IPO date; actual settlement completion and first execution price were not independently verified. | Final result, pages 3 and5 |
| Securities services | CIC CIB handles registered securities and financial services. An Indian IPO registrar category does not directly apply. | Prospectus, sections 4.1.3 and5.5.2 |
| Listing sponsor / agent | TP ICAP. | Euronext record |
Official source snapshots captured 26 October 2026 at 18:32 IST (13:02 UTC); source records retain the individual capture timestamps. The offer-result PDF, rather than the landing page’s initial offer size, controls the final figures above.
What the funding distinction means
Fresh shares increase the issuer’s capital; secondary sales transfer existing shares between holders. Gross proceeds also differ from the issuer’s estimated net receipts after transaction costs. Neither figure is operating revenue or profit. The proposed use of cash describes management’s intended deployment, not evidence that the spending is already complete.
What remains unverified
This is a retrospective offer report, not an invitation to apply. The French public subscription window has passed. The prospectus sets jurisdictional eligibility conditions; the one-share minimum must not be presented as universal access for Indian investors. No live quote, first-trade gain or independently confirmed settlement completion is reported here.
Readers should distinguish the fixed offer price from any subsequent exchange price and review the prospectus and its risk factors. Regulatory approval of an offer document is not an endorsement of the investment.
Sources: N4 final offer results dated 21 October 2026, AMF-approved offer note dated 8 October 2026 and Euronext IPO record. The original promotional release is linked for evidence, not reproduced.
AI-assisted report checked against linked primary documents; not independent human editorial approval. Publisher-designated author: Tatai. Information only, not investment advice.
Related CapKet coverage
For another example of separating the measures, read Lycia’s gross and estimated net IPO proceeds. This is separate coverage, not additional evidence for the figures above.
Exact source-capture times (UTC): N4 Group — 2026-10-26T13:02:35.902Z; N4 Group / AMF-approved prospectus — 2026-10-26T13:02:36.478Z; Euronext — 2026-10-26T13:02:38.853Z.
Recorded source observation: . This is a source-check timestamp, not a market quote or a new article update.